Professor Moher received a master’s degree in public health and epidemiology and a PhD in clinical epidemiology and biostatistics. Professor Moher is the founding director of the Centre for Journalology at the Ottawa Hospital Research Institute. Having pioneered the emerging field of Journalology (publication science), he is one of the most cited and impactful researchers in the world and has been recognized several times as one of the world’s most highly influential biomedical researchers by Clarivate Analytics.

Professor Moher has spent the last 30 years helping to develop reporting guidelines: he led the original CONSORT statement for randomized trials and PRISMA statement for systematic reviews, and has been actively involved in the development of many other reporting guidelines. Professor Moher also spearheaded the initial guidance on how to develop reporting guidelines and is participating in the update of this guidance. For most of the last decade Professor Moher’s focus has been in open science.

A leading expert in Chinese medicine clinical studies, Professor Bian Zhaoxiang has made a seminal contribution to the research of Chinese medicine in gastrointestinal diseases, such as colorectal cancer, irritable bowel syndrome (IBS), chronic constipation and inflammatory bowel disease (IBD), which have become increasingly common. Although Western medicine has provided cures for these diseases, patients are constantly afflicted by the side effects that accompany treatment. Therefore, more and more patients are turning to Chinese medicine, which not only has proven effectiveness but also fewer side effects.

Professor An-Wen Chan is a clinical epidemiologist and Mohs micrographic skin cancer surgeon at Women’s College Hospital, Toronto. He is the Phelan Senior Scientist at Women’s College Research Institute and Professor of Medicine (Dermatology) at University of Toronto. His research focuses on developing ways to improve the quality and transparency of clinical trials, as well as preventing and managing high-risk skin cancer, particularly in solid organ transplant recipients. Dr. Chan leads the international SPIRIT initiative to improve the quality of clinical trial protocols, and chairs the Advisory Panel of the World Health Organization’s International Clinical Trials Registry Platform. He is Vice-Chair of the Advisory Board for the Canadian Institutes of Health Research – Institute of Musculoskeletal Health and Arthritis. Every year since 2004, Dr. Chan has published in the top general medical journals worldwide, including Lancet, JAMA, and BMJ.

Sally Hopewell is a member of the advisory board for Current Controlled Trials, a member of the NIHR Health Technology Assessment Clinical Evaluation and Trials Board, a member of the NIHR Open Research Advisory Board, and member of the Oxford Clinical Trials Research Unit. She has published a number of research studies in the areas of design, conduct and transparent reporting of randomized trials and systematic reviews, including the development of key reporting guidelines such as the CONSORT Statement and PRISMA for Abstracts. She was awarded a D.Phil at the University of Oxford on research into the effects of unpublished data in systematic reviews, and has prior experience at the Centre for Statistics in Medicine, Centre d’Epidemiologie Clinique University Paris Descartes, the UK Cochrane Centre, and the NHS National Blood Service.

Diana Elbourne obtained a BSc (Social Administration) from London School of Economics (LSE), an MSc (Stats) at Brunel University, and a PhD from LSE. From 1981-1996 she was at the National Perinatal Epidemiology Unit in Oxford, holding the roles of social statistician, trials statistician, Deputy Director and later Director of the Perinatal Trials Service, where she was involved in a large number of RCTs and systematic reviews, and she continued this applied research after moving to the Medical Statistics Department (MSD) at the London School of Hygiene and Tropical Medicine (LSHTM) in 1997. Dr. Elbourne’s main interest as a statistician is in randomised controlled trials (RCTs). As a triallist she works with a highly experienced team in the MSD and the LSHTM Clinical Trials Unit to design, co-ordinate, analyse and report a number of RCTs - currently these trials include maternal and neonatal health trials and after school trials in India, and cardiac care in the UK and Germany.

Nikolaos Pandis received his degree of dental surgery at the University of Athens, Greece and his orthodontic specialty training at The Ohio State University, USA. In addition, he has received training in clinical research methodology that led to an MSc in clinical trials (London School of Hygiene & Tropical Medicine, UK), PhD in Epidemiology (Department of Hygiene & Epidemiology, Medical School, University of Ioannina, Greece)and MS in Biostatistics (University of Hasselt, Belgium). He is currently an associate professor at the University of Bern, Switzerland and maintains a private practice in Corfu, Greece.

Matthew Page is a Senior Research Fellow and Deputy Head of the Methods in Evidence Synthesis Unit in the School of Public Health and Preventive Medicine at Monash University. He has led many studies investigating the transparency, reproducibility and risk of bias in systematic reviews and the studies they include, and has developed methods to address these issues. He co-led the PRISMA 2020 statement for systematic reviews and is an associate scientific editor for the Cochrane Handbook for Systematic Reviews of Interventions. He is the current President of the Association for Interdisciplinary Meta-research and Open Science (AIMOS).

Matthew McInnes completed his radiology training at the University of Toronto in 2006, followed by a 1 year clinical fellowship at the University Health Network at the University of Toronto in Abdominal Imaging. He is a Professor of Radiology and Epidemiology at the University of Ottawa and works as a Radiologist in the divisions of Abdominal and Chest radiology in the Department of Medical Imaging at the Ottawa Hospital. He is a Scientist in the OHRI Clinical Epidemiology program. He completed a PhD in Clinical Epidemiology at the University of Amsterdam (2018).

Dr. Sanam Ebrahimzadeh is a postdoctoral fellow at the Ottawa Hospital Research Institute where her research focuses on systematic reviews and transparency in healthcare research. Sanam holds a Master’s degree in information science from Tehran University and a Ph.D. in information science from Alzahra University. She conducted part of her doctoral work on information-seeking behavior as a visiting researcher at McGill University.

Gary Collins is a professor of medical statistics, director of the Centre for Statistics in Medicine, and director of the UK EQUATOR Centre at the University of Oxford. His primary area of research is in the design, methodological conduct, reporting, synthesis and appraisal of clinical prediction studies, and has published extensively in this area. In addition to developing the TRIPOD statement for reporting clinical prediction models, he is currently leading an initiative to develop new guidance for prediction models developed using artificial intelligence/machine learning (TRIPOD-AI). He is currently involved in updating the SPIRIT and CONSORT statements for protocols and reports of clinical trials.

Manoj Lalu is an Anesthesiologist and an Associate Professor in the Department of Anesthesiology and Pain Medicine at the Ottawa Hospital Research Institute, University of Ottawa. His current research is largely preclinical and translational, focusing on novel therapies (e.g., cellular therapies for inflammatory diseases). He is also a member of the Ottawa Hospital Research Institute Centre Centre for Journalology where he has a special interest in preclinical reporting and transparency.

Matthew Jeffers is a PhD student in the School of Epidemiology and Public Health, University of Ottawa and the Clinical Epidemiology Program, Ottawa Hospital Research Institute. He previously managed a research program in preclinical stroke recovery and rehabilitation, testing novel health interventions using animal models of stroke. His current research focuses on decision-making criteria for advancement of new interventions to clinical trials, and optimal trial designs for late-phase preclinical and early-phase clinical trials. He received a B.Sc. (Hons; 2009) in psychology from the University of Manitoba, and an M.Sc. (2012) in medicine (neurosciences) from Memorial University of Newfoundland.

Cory Goldstein is a postdoctoral fellow with the Clinical Epidemiology Program at the Ottawa Hospital Research Institute and the School of Epidemiology and Public Health at the University of Ottawa. As a philosopher specializing in research ethics, his interests lie at the intersection of ethics and clinical trial design. Dr. Goldstein is currently working with an international team of ethicists, health providers, scientists, patient partners, and members of the public to co-develop and disseminate guidance for the ethical design and conduct of cluster randomized trials. He received a B.A. (2014) in philosophy from McGill University, and an M.A. (2016) and Ph.D. (2022) in philosophy from Western University.

Robert Thibault is a Postdoctoral Scholar with the Meta-Research Innovation Center at Stanford University (METRICS). His work focuses on developing and evaluating solutions to make research more rigorous and reproducible. These interests include effective study design, preregistration, statistical practice, peer review, and the funding and publication systems.